Chargement en cours...
AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer
Ovarian carcinoma is the most deadly gynecological malignancy. Current chemotherapeutic drugs are only transiently effective and patients with advance disease often develop resistance despite significant initial responses. Mounting evidence suggests that anti-apoptotic proteins, including those of t...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Landes Bioscience
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3679100/ https://ncbi.nlm.nih.gov/pubmed/22669575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.20563 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|